Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 13, 1978 - Issue 1
Submit an article Journal homepage
34
Views
101
CrossRef citations to date
0
Altmetric
Original Article

Metronidazole in Crohn's Disease

A Double Blind Cross-over Clinical Trial

Per Blichfeldt Medical Dept. A, National Hospital of Norway, Rikshospitalet, Oslo, Norway
,
Jan P. Blomhoff Medical Dept. A, National Hospital of Norway, Rikshospitalet, Oslo, Norway
,
Erik Myhre Medical Dept. A, National Hospital of Norway, Rikshospitalet, Oslo, Norway
&
Egil Gjone Medical Dept. A, National Hospital of Norway, Rikshospitalet, Oslo, Norway
Pages 123-127 | Received 08 Sep 1977, Accepted 26 Oct 1977, Published online: 23 Feb 2010

Citations (101)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (8)

Pramodini B Kale-Pradhan, Jing J Zhao, Jennifer R Palmer & Sheila M Wilhelm. (2013) The role of antimicrobials in Crohn’s disease. Expert Review of Gastroenterology & Hepatology 7:3, pages 281-288.
Read now
William Chamberlin, Thomas J Borody & Jordana Campbell. (2011) Primary treatment of Crohn’s disease: combined antibiotics taking center stage. Expert Review of Clinical Immunology 7:6, pages 751-760.
Read now
John K Triantafillidis, Emmanuel Merikas & Filippos Georgopoulos. (2011) Current and emerging drugs for the treatment of inflammatory bowel disease. Drug Design, Development and Therapy 5, pages 185-210.
Read now
Sandra Macfarlane, Helen Steed & George T. Macfarlane. (2009) Intestinal bacteria and inflammatory bowel disease. Critical Reviews in Clinical Laboratory Sciences 46:1, pages 25-54.
Read now
E. Lind, O. Fausa, E. Gjone & S. B. Mogensen. (1985) Crohn's Disease: Treatment and Outcome. Scandinavian Journal of Gastroenterology 20:8, pages 1014-1018.
Read now
Aud Krook, Jan Kjellander & Dan Danielsson. (1982) Susceptibility of Bacteroides Species to Metronidazole during Treatment of Patients with Crohn's Disease and Healthy Individuals. Scandinavian Journal of Infectious Diseases 14:1, pages 45-48.
Read now
A. Krook, D. Danielsson, J. Kjellander & G. Järnerot. (1981) The Effect of Metronidazole and Sulfasalazine on the Fecal Flora in Patients with Crohn's Disease. Scandinavian Journal of Gastroenterology 16:2, pages 183-192.
Read now
A. Krook, D. Danillsson, J. Kjellander & G. Järnerot. (1979) Changes in the Fecal Flora of Patients with Crohn's Disease During Treatment with Metronidazole. Scandinavian Journal of Gastroenterology 14:6, pages 705-710.
Read now

Articles from other publishers (93)

Ashley Gilliland, Jocelyn J. Chan, Travis J. De Wolfe, Hyungjun Yang & Bruce A. Vallance. (2023) Pathobionts in Inflammatory Bowel Disease: Origins, Underlying Mechanisms, and Implications for Clinical Care. Gastroenterology.
Crossref
Lily Peikova, Stefan Balkanski & Maya Georgieva. (2022) Methods for Analysis of Fluorinated Quinolones in Mixtures with Nitroimidazole Antibacterial Drugs. Current Pharmaceutical Analysis 18:10, pages 968-982.
Crossref
Cassandra M Townsend, Claire E Parker, John K MacDonald, Tran M Nguyen, Vipul Jairath, Brian G Feagan & Reena Khanna. (2019) Antibiotics for induction and maintenance of remission in Crohn's disease. Cochrane Database of Systematic Reviews.
Crossref
Rajmohan Dharmaraj, Melodee Nugent, Pippa Simpson, Marjorie Arca, Bhaskar Gurram & Steven Werlin. (2018) Outcomes after fecal diversion for colonic and perianal Crohn disease in children. Journal of Pediatric Surgery 53:3, pages 472-476.
Crossref
P.C. Barko, M.A. McMichael, K.S. Swanson & D.A. Williams. (2018) The Gastrointestinal Microbiome: A Review. Journal of Veterinary Internal Medicine 32:1, pages 9-25.
Crossref
Nicole Parrish, Aravinda Vadlamudi & Neil Goldberg. (2017) Anaerobic adaptation of Mycobacterium avium subspecies paratuberculosis in vitro: similarities to M. tuberculosis and differential susceptibility to antibiotics. Gut Pathogens 9:1.
Crossref
Sreedhar Subramanian, Anders Ekbom & Jonathan M Rhodes. (2017) Recent advances in clinical practice: a systematic review of isolated colonic Crohn's disease: the third IBD?. Gut 66:2, pages 362-381.
Crossref
Paolo Gionchetti, Carlo Calabrese, Andrea Calafiore & Fernando Rizzello. 2017. Crohn's Disease and Ulcerative Colitis. Crohn's Disease and Ulcerative Colitis 455 469 .
Wee-Chian Lim, Yongjun Wang, John K MacDonald & Stephen Hanauer. (2016) Aminosalicylates for induction of remission or response in Crohn's disease. Cochrane Database of Systematic Reviews 2016:7.
Crossref
Mario Matijašić, Tomislav Meštrović, Mihaela Perić, Hana Čipčić Paljetak, Marina Panek, Darija Vranešić Bender, Dina Ljubas Kelečić, Željko Krznarić & Donatella Verbanac. (2016) Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients. International Journal of Molecular Sciences 17:4, pages 578.
Crossref
Antonella Gallo, Giovanna Passaro, Antonio Gasbarrini, Raffaele Landolfi & Massimo Montalto. (2016) Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate. World Journal of Gastroenterology 22:32, pages 7186.
Crossref
F. W. Booth. (2015) Muscle adaptation to exercise: New Saltin’s paradigms. Scandinavian Journal of Medicine & Science in Sports 25, pages 49-52.
Crossref
Peter Hawker & Rakesh Sinha. 2015. Crohn's Disease. Crohn's Disease 163 171 .
. 2014. Intestinal Microbiota in Health and Disease. Intestinal Microbiota in Health and Disease 229 237 .
Roberto Lorenzetti & Cosimo Prantera. (2013) Rationale for the use of rifaximin in inflammatory bowel diseases based on clinical trial results. Clinical Investigation 3:12, pages 1187-1193.
Crossref
SHENG-LAN WANG, ZHI-RONG WANG & CHANG-QING YANG. (2012) Meta-analysis of broad-spectrum antibiotic therapy in patients with active inflammatory bowel disease. Experimental and Therapeutic Medicine 4:6, pages 1051-1056.
Crossref
Dawn M. Wiese & David A. Schwartz. (2012) Managing Perianal Crohn’s Disease. Current Gastroenterology Reports 14:2, pages 153-161.
Crossref
Cosimo Prantera, Herbert Lochs, Maria Grimaldi, Silvio Danese, Maria Lia Scribano & Paolo Gionchetti. (2012) Rifaximin-Extended Intestinal Release Induces Remission in Patients With Moderately Active Crohn's Disease. Gastroenterology 142:3, pages 473-481.e4.
Crossref
Paolo Gionchetti & Fernando Rizzello. 2012. Crohn's Disease and Ulcerative Colitis. Crohn's Disease and Ulcerative Colitis 517 534 .
J. Huang, C. Liao, L. Wu, Y. Cao & F. Gao. (2011) A meta-analysis of randomized controlled trials comparing antibacterial therapy with placebo in Crohn’s disease. Colorectal Disease 13:6, pages 617-626.
Crossref
Rosana B. R. Ferreira, Navkiran Gill, Benjamin P. Willing, L. Caetano M. Antunes, Shannon L. Russell, Matthew A. Croxen & B. Brett Finlay. (2011) The Intestinal Microbiota Plays a Role in Salmonella-Induced Colitis Independent of Pathogen Colonization. PLoS ONE 6:5, pages e20338.
Crossref
M. Wlodarska, B. Willing, K. M. Keeney, A. Menendez, K. S. Bergstrom, N. Gill, S. L. Russell, B. A. Vallance & B. B. Finlay. (2011) Antibiotic Treatment Alters the Colonic Mucus Layer and Predisposes the Host to Exacerbated Citrobacter rodentium -Induced Colitis . Infection and Immunity 79:4, pages 1536-1545.
Crossref
John Keohane & Fergus Shanahan. 2010. Inflammatory Bowel Disease. Inflammatory Bowel Disease 392 401 .
Ira Shafran & Patricia Burgunder. (2010) Adjunctive Antibiotic Therapy with Rifaximin May Help Reduce Crohn’s Disease Activity. Digestive Diseases and Sciences 55:4, pages 1079-1084.
Crossref
Eun Soo Kim & Won Ho Kim. (2010) Inflammatory Bowel Disease in Korea: Epidemiological, Genomic, Clinical, and Therapeutic Characteristics. Gut and Liver 4:1, pages 1-14.
Crossref
Gary R Lichtenstein, Stephen B Hanauer & William J Sandborn. (2009) Management of Crohn's Disease in Adults. The American Journal of Gastroenterology 104:2, pages 465-483.
Crossref
Saleh Alqhatani, Lloyd Sutherland & Remo Panaccione. (2008) Are antibiotics useful in the treatment of IBD?. Inflammatory Bowel Diseases 14:Supplement, pages S249-S250.
Crossref
Saleh Alqhatani, Lloyd Sutherland & Remo Panaccione. (2008) Are antibiotics useful in the treatment of IBD?. Inflammatory Bowel Diseases 14, pages S249-S250.
Crossref
Leo R. Fitzpatrick, Jeffrey Small, Robert A. Hoerr, Eileen F. Bostwick, Lynn Maines & Walter A. Koltun. (2008) In vitro and in vivo effects of the probiotic Escherichia coli strain M-17: immunomodulation and attenuation of murine colitis. British Journal of Nutrition 100:03, pages 530-541.
Crossref
Gert De Hertogh. (2008) Evidence for the involvement of infectious agents in the pathogenesis of Crohn’s disease. World Journal of Gastroenterology 14:06, pages 845.
Crossref
Patricia L Kozuch & Stephen B Hanauer. (2008) Treatment of inflammatory bowel disease: A review of medical therapy. World Journal of Gastroenterology 14:3, pages 354.
Crossref
. 2008. Surgery of the Anus, Rectum & Colon. Surgery of the Anus, Rectum & Colon 1995 2023 .
H. A. Akpinar. 2008. IBD 2007 — Achievements in Research and Clinical Practice. IBD 2007 — Achievements in Research and Clinical Practice 221 231 .
P. Gionchetti, F. Rizzello, C. Morselli, R. Tambasco & M. Campieri. 2008. IBD 2007 — Achievements in Research and Clinical Practice. IBD 2007 — Achievements in Research and Clinical Practice 162 175 .
W. J. SANDBORN, B. G. FEAGAN & G. R. LICHTENSTEIN. (2007) Medical management of mild to moderate Crohn’s disease: evidence-based treatment algorithms for induction and maintenance of remission. Alimentary Pharmacology & Therapeutics 26:7, pages 987-1003.
Crossref
Seymour Katz. (2007) “Mind the Gap”. Journal of Clinical Gastroenterology 41:9, pages 799-809.
Crossref
Roja Rahimi, Shekoufeh Nikfar, Ali Rezaie & Mohammad Abdollahi. (2006) A meta-analysis of broad-spectrum antibiotic therapy in patients with active Crohn's disease. Clinical Therapeutics 28:12, pages 1983-1988.
Crossref
Molly Perencevich & Robert Burakoff. (2006) Use of antibiotics in the treatment of inflammatory bowel disease. Inflammatory Bowel Diseases 12:7, pages 651-664.
Crossref
Carsten Büning & Herbert Lochs. (2006) Conventional therapy for Crohn’s disease. World Journal of Gastroenterology 12:30, pages 4794.
Crossref
Paolo Gionchetti. (2006) Antibiotics and probiotics in treatment of inflammatory bowel disease. World Journal of Gastroenterology 12:21, pages 3306.
Crossref
Séverine Vermeire & Paul Rutgeerts. 2006. Challenges in Inflammatory Bowel Disease. Challenges in Inflammatory Bowel Disease 206 212 .
TOSHIFUMI OHKUSA & NOBUHIRO SATO. (2005) Antibacterial and antimycobacterial treatment for inflammatory bowel disease. Journal of Gastroenterology and Hepatology 20:3, pages 340-351.
Crossref
Philippe Marteau & Fergus Shanahan. 2005. Inflammatory Bowel Disease: From Bench to Bedside. Inflammatory Bowel Disease: From Bench to Bedside 573 585 .
Gary E. Wild. (2004) The Role of Antibiotics in the Management of Crohnʼs Disease. Inflammatory Bowel Diseases 10:3, pages 321-323.
Crossref
W. J. Sandborn & B. G. Feagan. (2003) Mild to moderate Crohn's disease - defining the basis for a new treatment algorithm. Alimentary Pharmacology & Therapeutics 18:3, pages 263-277.
Crossref
M. Scribano & C. Prantera. (2003) Medical treatment of moderate to severe Crohn's disease. Alimentary Pharmacology & Therapeutics 17, pages 23-30.
Crossref
Philippe Marteau, Philippe Seksik & Fergus Shanahan. (2003) Manipulation of the bacterial flora in inflammatory bowel disease. Best Practice & Research Clinical Gastroenterology 17:1, pages 47-61.
Crossref
Philippe Marteau & Fergus Shanahan. 2003. Inflammatory Bowel Disease: From Bench to Bedside. Inflammatory Bowel Disease: From Bench to Bedside 573 585 .
M. L. Scribano & C. Prantera. (2002) Medical treatment of active Crohn's disease. Alimentary Pharmacology & Therapeutics 16, pages 35-39.
Crossref
Björn Blomberg & Gunnar Järnerot. (2000) Clinical Evaluation and Management of Acute Severe Colitis. Inflammatory Bowel Diseases 6:3, pages 214-227.
Crossref
R.J. Kennedy, S.J. Kirk & K.R. Gardiner. (2016) Promotion of a Favorable Gut Flora in Inflammatory Bowel Disease. Journal of Parenteral and Enteral Nutrition 24:3, pages 189-195.
Crossref
Geert D’Haens. (1999) Prevention of postoperative recurrence in Crohn’s disease. Current Gastroenterology Reports 1:6, pages 476-481.
Crossref
Geert DʼHaens & Paul Rutgeerts. (1999) Postoperative Recurrence of Crohnʼs Disease: Pathophysiology and Prevention. Inflammatory Bowel Diseases 5:4, pages 295-303.
Crossref
Vinton S. Chadwick & Wangxue Chen. 1999. Medical Importance of the Normal Microflora. Medical Importance of the Normal Microflora 177 221 .
Brian R. Stotland & Gary R. Lichtenstein. (1996) NEWER TREATMENTS FOR INFLAMMATORY BOWEL DISEASE. Primary Care: Clinics in Office Practice 23:3, pages 577-608.
Crossref
Mark G. Griffin & Philip B. MinerJrJr. (1995) CONVENTIONAL DRUG THERAPY IN INFLAMMATORY BOWEL DISEASE. Gastroenterology Clinics of North America 24:3, pages 509-521.
Crossref
Paul Rutgeerts, Martin Hiele, Karel Geboes, Marc Peeters, Freddy Penninckx, Raymond Aerts & Raymond Kerremans. (1995) Controlled trial of metronidazole treatment for prevention of crohn's recurrence after ileal resection. Gastroenterology 108:6, pages 1617-1621.
Crossref
M. S. Smith & A. J. Wakefield. (1994) Crohn's disease: ancient and modern.. Postgraduate Medical Journal 70:821, pages 149-153.
Crossref
Scott A. Strong & Victor W. Fazio. (1993) Crohn's Disease of the Colon, Rectum, and Anus. Surgical Clinics of North America 73:5, pages 933-963.
Crossref
WARWICK SELBY. (2008) Current management of inflammatory bowel disease. Journal of Gastroenterology and Hepatology 8:1, pages 70-83.
Crossref
Rex J. Polson & J.J. Misiewicz. (1992) Medical management of severe inflammatory disease of the rectum and distal colon: Non-nutritional aspects. Baillière's Clinical Gastroenterology 6:1, pages 1-26.
Crossref
George Earl DukesJr.Jr.. 1992. Applied Therapeutics. Applied Therapeutics 397 410 .
L Sutherland, J Singleton, J Sessions, S Hanauer, E Krawitt, G Rankin, R Summers, H Mekhjian, N Greenberger & M Kelly. (1991) Double blind, placebo controlled trial of metronidazole in Crohn's disease.. Gut 32:9, pages 1071-1075.
Crossref
William B. Ruderman. (1990) Newer Pharmacologic Agents for the Therapy of Inflammatory Bowel Disease. Medical Clinics of North America 74:1, pages 133-153.
Crossref
William M. Michener & Robert Wyllie. (1990) Management of Children and Adolescents with Inflammatory Bowel Disease. Medical Clinics of North America 74:1, pages 103-117.
Crossref
A. B. R. Thomson. 1990. Inflammatory Bowel Diseases 1990. Inflammatory Bowel Diseases 1990 179 211 .
Paul O. Gubbins & Karen E. Bertch. (2012) Drug Absorption in Gastrointestinal Disease and Surgery. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 9:5, pages 285-295.
Crossref
Arthur Allan & Michael R. B. Keighley. (1988) Management of perianal Crohn's disease. World Journal of Surgery 12:2, pages 198-202.
Crossref
William B. Ruderman & Richard G. Farmer. (1987) Current Management of Inflammatory Bowel Disease. Radiologic Clinics of North America 25:1, pages 221-232.
Crossref
N. S. Ambrose, R. N. Allan, M. R. B. Keighley, D. W. Burdon, Denise Youngs, P. Barnes & J. E. Lennard-Jones. (1985) Antibiotic therapy for treatment in relapse of intestinal Crohn's disease. Diseases of the Colon & Rectum 28:2, pages 81-85.
Crossref
J. M. Rhodes. (1983) THERAPEUTIC PROGRESS—REVIEWIX.. Journal of Clinical Pharmacy and Therapeutics 8:3, pages 219-232.
Crossref
David M. Sack & Mark A. Peppercorn. (2012) Drug Therapy of Inflammatory Bowel Disease. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 3:3, pages 158-176.
Crossref
F. A. Macrae. (1982) Inflammatory bowel disease. Medical Journal of Australia 2:8, pages 359-359.
Crossref
Tuvia Gilat. (1982) Metronidazole in Crohn's Disease. Gastroenterology 83:3, pages 702-704.
Crossref
Bo Ursing, Thor Alm, Franz Bárány, Ingemar Bergelin, Karin Ganrot-Norlin, Jürgen Hoevels, Bernhard Huitfeldt, Gunnar Jarnerot, Urban Krause, Aud Krook, Björn Lindström, Örjan Nordle & Anders Rosén. (1982) A Comparative Study of Metronidazole and Sulfasalazine for Active Crohn's Disease: The Cooperative Crohn's Disease Study in Sweden. Gastroenterology 83:3, pages 550-562.
Crossref
Lawrence J. Brandt, Leslie H. Bernstein, Scott J. Boley & Michael S. Frank. (1982) Metronidazole Therapy for Perineal Crohn's Disease: A Follow-Up Study. Gastroenterology 83:2, pages 383-387.
Crossref
J. W. Singleton. 1982. Inflammatory Bowel Diseases. Inflammatory Bowel Diseases 235 243 .
Ulrich R. Fölsch & Ulrich JungeUlrich R. Fölsch & Ulrich Junge. 1982. Medikamentöse Therapie in der Gastroenterologie. Medikamentöse Therapie in der Gastroenterologie 95 109 .
K. Müller-Wieland & W. Braun. 1982. Dickdarm. Dickdarm 639 707 .
Francis P. Tally & C. Edmond Sullivan. (2012) Metronidazole: In Vitro Activity, Pharmacology and Efficacy in Anaerobic Bacterial Infections. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 1:1, pages 28-38.
Crossref
A Krook, B Lindstrom, J Kjellander, G Jarnerot & L Bodin. (1981) Relation between concentrations of metronidazole and Bacteroides spp in faeces of patients with Crohn's disease and healthy individuals.. Journal of Clinical Pathology 34:6, pages 645-650.
Crossref
Anastasios Angelides & Joseph F. Fitzgerald. (1981) Pharmacologic Advances in the Treatment of Gastrointestinal Diseases. Pediatric Clinics of North America 28:1, pages 95-112.
Crossref
E.J. Baines & J.A. McFadzean. 1981. 223 272 .
G. Järnerot, B. Ursing, T. Alm, F. Bárány, I. Bergelin, K. Ganrot-Norlin, U. Krause, Aud Krook & A. Rosen. 1981. Recent Advances in Crohn’s Disease. Recent Advances in Crohn’s Disease 469 473 .
W. Berges, T. Stolze, M. Wienbeck, G. Lux, J. Femppel, P. C. Lederer, W. Domschke, W. Rösch, H. Kasper, C. Reiners, C. Eilles, W. Börner, H. K. Seitz, P. Czygan, H. Kienapfel, B. Kommerell, W. Rösch, A. Sonnenberg, D. Stucke, N. Hüsmert, S. A. Müller-Lissner, A. L. Blum, K.-H. Holtermüller, P. Herzog, R. Arnold, M. Rothmund, W. Seitz, P. John, H. Ruppin, C. Hartog, S. Domschke, J. Reimann, J. Ring, P. Wendt, R. Lorenz, B. Ultsch, K. Swoboda, G. Blümel, S. E. Miederer, M. Becker, P. Müller, N. Fischer, H. Kather, B. Simon, B. M. Peskar, K. Rainsford, K. Brune, W. Gerok, A. Springer, M. Pfreundschuh, G. E. Feurle, J. D. Beck, U. Karbach, K. Ewe, H. Bodenstein, M. U. Schneider, J. F. Riemann, S. Strobel, L. Demling, K. J. Goerg, K. H. Soergel, R. Wanitschke, C. M. Wood, F. Kluge, H. Grosse-Wilde, K. Krumbacher, H. Schmidt, K. H. Holtermüller, P. Frühmorgen, H.-P. Buscher, H. Abberger, K. Fuchte, G. Kurz, G. Bandomer, F. Begemann, W. Krüger, V. Schumpelick, R. Raedsch, A. Stiehl, R. Götz, S. Walker, R. Götz, H. Seitz, E. Weber, U. M. Farack, G. Nell & O. Lueg. 1981. Verhandlungen der Deutschen Gesellschaft für innere Medizin. Verhandlungen der Deutschen Gesellschaft für innere Medizin 802 877 .
Jan Koch-Weser & Peter Goldman. (1980) Metronidazole. New England Journal of Medicine 303:21, pages 1212-1218.
Crossref
John W. Singleton. (1980) Medical Therapy of Inflammatory Bowel Disease. Medical Clinics of North America 64:6, pages 1117-1133.
Crossref
David B. Sachar. (1980) Metronidazole for Crohn's disease—Breakthrough or ballyhoo?. Gastroenterology 79:2, pages 393-395.
Crossref
Leslie H. Bernstein, Michael S. Frank, Lawrence J. Brandt & Scott J. Boley. (1980) Healing of perineal Crohn's disease with metronidazole. Gastroenterology 79:2, pages 357-365.
Crossref
POVL RIIS. (1980) A Critical Survey of Controlled Studies in the Treatment of Ulcerative Colitis and Crohn’s Disease. Clinics in Gastroenterology 9:2, pages 351-369.
Crossref
J.E. LENNARD-JONES & JEREMY POWELL-TUCK. (1979) Drug Treatment of Inflammatory Bowel Disease. Clinics in Gastroenterology 8:1, pages 187-217.
Crossref
H. Fahrländer. 1979. Verhandlungen der Deutschen Gesellschaft für innere Medizin. Verhandlungen der Deutschen Gesellschaft für innere Medizin 52 65 .
A. L. Blum. 1979. Verhandlungen der Deutschen Gesellschaft für innere Medizin. Verhandlungen der Deutschen Gesellschaft für innere Medizin 111 121 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.